Epigenetic drug discovery and tools
 

Management and Board

Management

 

    Barrie Ward   Executive Chairman
    Will West   Chief Executive
    Tim Fell  Chief Operating Officer
    David Knowles  Chief Scientific Officer
    Nessa Carey  Director of Exploratory Research
    Neil Pegg Director of Discovery Research
    Jonathan Best Programme Manager
    Dev Crease  Patent Counsel
    Richard Brooks Finance Director
    Thea Stanway  Finance Officer

  

Board

 

    Barrie Ward  Executive Chairman
    Will West  Executive Director
    Tim Fell Executive Director
    David Knowles Executive Director
    Gerald Chan Non-Executive Director
    Sue Foden Non-Executive Director
    Dan Roach Non-Executive Director
    David Secher Non-Executive Director
    Azim Surani Board Observer

 

  

David Secher

David SecherDavid is an independent consultant at Cambridge Knowledge Transfer and the Chairman of Praxis-Unico, the UK market leader in technology transfer training. Prior to this he was the founding CEO of N8, the alliance of the eight research-intensive universities in Northern England.  His earlier experience includes Director of Research Services at the University of Cambridge, where he was responsible for technology transfer, research policy and for the management of the university’s research funds (£180m pa); R&D management in the Biotech and Pharmaceutical industries; and clinical trial management at the Cancer Research Campaign.

 

For 16 years he was an academic research scientist at the MRC Laboratory of Molecular Biology in Cambridge, where he discovered and patented the first monoclonal antibody to interferon. He has advised many companies and individuals on commercialising intellectual property. In 2002 he founded Praxis, with Lita Nelsen of MIT, to bring best practice in technology transfer to the UK.  In  2007 he was awarded the Queen's Award for Enterprise Promotion.